Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275717 · ClinicalTrials.gov registry record
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT00275717: Completed study, sponsored by Mayo Clinic.
NCT00275717 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275717 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by antibody producing cells.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275717
The ClinicalTrials.gov registry entry for NCT00275717 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00275717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00275717 about?
NCT00275717 is a clinical study titled "A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.". This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by antibody produci...
What is the current status of trial NCT00275717?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2005-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00275717?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.